Redefining success: predicting checkpoint inhibitor toxicity to improve patient outcomes

Immuno-Oncology Insights 2022; 3(6), –314

DOI: 10.18609/ioi.2022.030

Published: 15 June 2022
Viewpoint
Joanne Weidhaas

“Immunotherapy represents a new era in which toxicity has become an incredibly important consideration in treatment... harnessing immunity can be very powerful, but can lead to very severe sequelae and toxicity, and these toxicities can be life ending.”